PL370065A1 - Pochodne 5-(pirydyn-3-ylo)-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne - Google Patents

Pochodne 5-(pirydyn-3-ylo)-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne

Info

Publication number
PL370065A1
PL370065A1 PL03370065A PL37006503A PL370065A1 PL 370065 A1 PL370065 A1 PL 370065A1 PL 03370065 A PL03370065 A PL 03370065A PL 37006503 A PL37006503 A PL 37006503A PL 370065 A1 PL370065 A1 PL 370065A1
Authority
PL
Poland
Prior art keywords
azabicyclo
pyridin
therapeutics
octane
derivatives
Prior art date
Application number
PL03370065A
Other languages
English (en)
Other versions
PL216665B1 (pl
Inventor
Frederic Galli
Odile Leclerc
Alistair Lochead
Alain Nedelec
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of PL370065A1 publication Critical patent/PL370065A1/pl
Publication of PL216665B1 publication Critical patent/PL216665B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL370065A 2002-01-07 2003-01-03 Pochodne 5-(pirydynylo)-1-azabicyklo[3.2.1]oktanu oraz środek farmaceutyczny PL216665B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200109A FR2834511B1 (fr) 2002-01-07 2002-01-07 Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
PL370065A1 true PL370065A1 (pl) 2005-05-16
PL216665B1 PL216665B1 (pl) 2014-04-30

Family

ID=8871176

Family Applications (1)

Application Number Title Priority Date Filing Date
PL370065A PL216665B1 (pl) 2002-01-07 2003-01-03 Pochodne 5-(pirydynylo)-1-azabicyklo[3.2.1]oktanu oraz środek farmaceutyczny

Country Status (35)

Country Link
US (2) US7223750B2 (pl)
EP (1) EP1465893B1 (pl)
JP (1) JP4402957B2 (pl)
KR (1) KR100977332B1 (pl)
CN (2) CN1911928A (pl)
AR (2) AR038098A1 (pl)
AT (1) ATE355290T1 (pl)
AU (1) AU2003216777B2 (pl)
BR (1) BR0306707A (pl)
CA (1) CA2471628C (pl)
CO (1) CO5590914A2 (pl)
CY (1) CY1106580T1 (pl)
DE (1) DE60312123T2 (pl)
DK (1) DK1465893T3 (pl)
EA (1) EA007793B1 (pl)
EC (1) ECSP045176A (pl)
ES (1) ES2281631T3 (pl)
FR (1) FR2834511B1 (pl)
HR (1) HRP20040617B1 (pl)
IL (2) IL162524A0 (pl)
IS (1) IS2470B (pl)
MA (1) MA27165A1 (pl)
ME (2) ME00213B (pl)
MX (1) MXPA04006630A (pl)
NO (1) NO329309B1 (pl)
NZ (1) NZ533793A (pl)
PL (1) PL216665B1 (pl)
PT (1) PT1465893E (pl)
RS (1) RS50921B (pl)
SI (1) SI1465893T1 (pl)
TN (1) TNSN04120A1 (pl)
TW (1) TWI336703B (pl)
UA (1) UA77229C2 (pl)
WO (1) WO2003057697A1 (pl)
ZA (1) ZA200405002B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902007D0 (en) * 1999-01-30 1999-03-17 Thomas Carpentry Services Limi Improvements relating to door frames
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique
FR2889701B1 (fr) * 2005-08-12 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridinyl-1-azabicyclo[3.2.1]octane, leur preparation en therapeutique.
FR2889847B1 (fr) 2005-08-18 2007-10-05 Sanofi Aventis Sa Derives de 5-pyridazinyl-1-azabicyclo[3.2.1]octave, leur preparation en therapeutique.
FR2912404B1 (fr) * 2007-02-09 2009-04-10 Sanofi Aventis Sa Derives d'azabicycloalkane,leur preparation et leur application en therapeutique.
KR101928505B1 (ko) 2011-01-28 2018-12-12 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
KR101925971B1 (ko) * 2011-01-28 2018-12-06 에스케이바이오팜 주식회사 피리돈 유도체 및 이를 포함하는 약학적 조성물
WO2019087149A1 (en) 2017-11-03 2019-05-09 Novartis Ag Azabicyclo and diazepine derivatives for treating ocular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817679A (en) * 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
AU7474794A (en) 1993-07-22 1995-02-20 E.I. Du Pont De Nemours And Company Arthropodicidal azacyclic heterocycles
FR2786769B1 (fr) * 1998-12-04 2002-10-25 Synthelabo Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2834511B1 (fr) * 2002-01-07 2004-02-13 Sanofi Synthelabo Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
TNSN04120A1 (fr) 2006-06-01
CN1911928A (zh) 2007-02-14
DE60312123T2 (de) 2007-09-13
JP2005514422A (ja) 2005-05-19
HK1066547A1 (en) 2005-03-24
KR100977332B1 (ko) 2010-08-20
US7223750B2 (en) 2007-05-29
NO329309B1 (no) 2010-09-27
NZ533793A (en) 2007-01-26
ZA200405002B (en) 2006-05-31
DK1465893T3 (da) 2007-06-04
BR0306707A (pt) 2005-02-09
CO5590914A2 (es) 2005-12-30
EP1465893A1 (fr) 2004-10-13
NO20042846L (no) 2004-09-21
PL216665B1 (pl) 2014-04-30
UA77229C2 (uk) 2006-11-15
AR086573A2 (es) 2014-01-08
CN1276921C (zh) 2006-09-27
AR038098A1 (es) 2004-12-29
EA200400770A1 (ru) 2004-12-30
ES2281631T3 (es) 2007-10-01
AU2003216777A1 (en) 2003-07-24
CY1106580T1 (el) 2012-01-25
HRP20040617B1 (hr) 2012-10-31
US20070185137A1 (en) 2007-08-09
WO2003057697A1 (fr) 2003-07-17
RS59904A (sr) 2006-10-27
RS50921B (sr) 2010-08-31
US7585974B2 (en) 2009-09-08
US20050020568A1 (en) 2005-01-27
ME00213B (me) 2011-02-10
SI1465893T1 (sl) 2007-08-31
FR2834511B1 (fr) 2004-02-13
IS7322A (is) 2004-06-16
ECSP045176A (es) 2004-08-27
HRP20040617A2 (en) 2004-10-31
CN1612876A (zh) 2005-05-04
MXPA04006630A (es) 2004-11-10
CA2471628C (en) 2011-03-22
PT1465893E (pt) 2007-05-31
MA27165A1 (fr) 2005-01-03
MEP24408A (en) 2010-10-10
FR2834511A1 (fr) 2003-07-11
AU2003216777B2 (en) 2008-10-02
IL162524A0 (en) 2005-11-20
KR20040077705A (ko) 2004-09-06
IL162524A (en) 2010-05-17
EA007793B1 (ru) 2007-02-27
IS2470B (is) 2008-12-15
TWI336703B (en) 2011-02-01
CA2471628A1 (en) 2003-07-17
DE60312123D1 (de) 2007-04-12
JP4402957B2 (ja) 2010-01-20
TW200305413A (en) 2003-11-01
ATE355290T1 (de) 2006-03-15
EP1465893B1 (fr) 2007-02-28

Similar Documents

Publication Publication Date Title
IL191960A (en) History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
AU3301800A (en) 1,4-diazabicyclo(3.2.2)nonane-4-carboxylate and carboxamide derivatives, production and use thereof in therapeutics
IL219670A0 (en) [ 1,2,4] triazolo [4,3-a] pyridines and use thereof in the preparation of a medicament
IL166129A (en) Annals of 5 - (h1 - indoliloxy) - pyrollo [1,2 - f] [4,2,1] Triazine and Pharmaceuticals containing them
EP1548024A4 (en) PYRAZOLE DERIVATIVES, DRUG COMPOSITION CONTAINING THESE DERIVATIVES, MEDICAL USE OF THESE DERIVATIVES AND INTERMEDIATE FOR THE PRODUCTION OF THESE DERIVATIVES
IL172994A0 (en) Substituted tetrahydro-1h-pyrazolo[3,4-c]pyridines, compositions containing them, and use
MXPA03005713A (es) Derivados de tetrahidropiridina, su preparacion y su uso como inhibidores de proliferacion celular.
AU2003289440A1 (en) Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof
ZA200410211B (en) Quinuclidine derivatives and pharmaceutical compositions containing the same.
NO20043565L (no) Heteroaryl-substituerte 2-pyridinyl- og 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater.
ZA978970B (en) 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, their preparation and their application in therapeutics.
ZA200001746B (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use.
AP2329A (en) 2-Substituted phenyl-5, 7-dihydrocarbyl-3, 7-dihydropyrrolo [2,3-d] pyrimidin-4 - one derivatives, the preparation and the pharmaceutical use thereof.
AU2003244727A1 (en) Novel podophyllotoxin derivatives, the production thereof and the use of the same in therapeutics
PL370065A1 (pl) Pochodne 5-(pirydyn-3-ylo)-1-azabicyklo[3.2.1]oktanu, ich wytwarzanie i ich zastosowanie terapeutyczne
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
AU2001252132A1 (en) Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/ortreatment of anemias
ZA200800966B (en) Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
AU2003292285A1 (en) Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, preparation thereof and application of same in therapeutics
ZA200001747B (en) 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use.
AU2001282663A1 (en) Composition comprising chromium picolinate, method of preparing the same and usethereof
HUP0402149A3 (en) Water-soluble phenylpyridazine derivatives, their use and pharmaceutical compositions containing the same
SI1556380T1 (sl) Derivati piridoindolona, substituirani v legi 3 sheterociklicno skupino, njihova priprava in njihova terapevtska uporaba
AU2001262417A1 (en) Polyisosilicate adherence primer composition, in particular for coating siliconeelastomers and one of the methods for preparing same

Legal Events

Date Code Title Description
RECP Rectifications of patent specification